Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.10.5731

Improved Detection of Metastases by Step Sectioning and Immuno-Histochemical Staining of Axillary Sentinel Nodes in Patients with Breast Carcinoma  

Ensani, Fereshteh (Department of Pathology, Iran Cancer Institute, Emam Khomeini Hospital)
Enayati, Ladan (Department of Pathology, Iran Cancer Institute, Emam Khomeini Hospital)
Rajabiani, Afsaneh (Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences)
Omranipour, Ramesh (Department of Pathology, Iran Cancer Institute, Emam Khomeini Hospital)
Alavi, Nasrinalsadat (Department of Surgery, Breast Cancer Research Center, Iranian Breast Cancer Research Center (IBCRC), Academic Center of Education Culture and Research (ACECR))
Mosahebi, Sara (Department of Surgery, Breast Cancer Research Center, Iranian Breast Cancer Research Center (IBCRC), Academic Center of Education Culture and Research (ACECR))
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.10, 2013 , pp. 5731-5734 More about this Journal
Abstract
Background: The object of this study was to examine whether a new protocol including step-sectioning and immunohistochemistry (IHC) staining of axillary sentinel nodes (SN) would lead to detection of more metastases in patients with breast cancer. Materials and Methods: Sixty-nine tumor free sentinel lymph nodes were examined. Step frozen sectioning was performed on formalin fixed SN and stained both by hematoxylin and eosin (H and E) and cytokeratin markers using IHC. Any tumoral cell in IHC stained slides were considered as a positive result. Metastases up to 0.2 mm were considered as isolated tumor cells and 0.2 up to 2 mm as micrometastasis. Results: Mean age of the patients was $48.7{\pm}12.2$ years. Step sectioning of the SN revealed 11 involved by metastasis which was statistically significant (p<0.001). Furthermore, 15 (21.7%) of the patients revealed positive results in IHC staining for pan-CK marker and this was also statistically significant (p=0.001). Ten patients had tumoral involvement in lymph nodes harvested from axillary dissection and 4 out of 15 lymph nodes with positive result for CK marker were isolated tumor cells. However, 4 of 10 patients with tumor positive lymph nodes in axillary dissection were negative for CK marker and in contrast 6 of the pan-CK positive SN were in patients with tumor-free axillary lymph nodes. Conclusions: Both IHC and step sectioning improve the detection rate of metastases. Considering the similar power of these two methods, we recommend using either IHC staining or step sectioning for better evaluation of harvested SNs.
Keywords
Breast cancer; sentinel node (SN) dissection; multilayer sectioning; immunohistochemistry;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chagpar A, Middleton LP, Sahin AA et al (2005). Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer, 103, 1581-6.   DOI   ScienceOn
2 Czerniecki BJ, Scheff AM, Callans LS, et al (1999). Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer, 85, 1098-103.   DOI
3 De Boer M, van Deurzen CH, van Dijck JA, et al (2009). Micrometastases or Isolated Tumor Cells and The Outcome of Breast Cance. N Eng J Med, 361, 653-63.   DOI   ScienceOn
4 De Boer M, Van Dijck JAAM, Bult PGF, et al (2010). Tjan-Heijnen. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst, 102, 410-25.   DOI   ScienceOn
5 Dowlatshahi K, Fan M, Bloom K, et al (1999). Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A Preliminary Study Cancer, 86, 990-6.
6 Freneaux PP, Nos C, Salomon AV, et al (2002). Histological Detection of Minimal Metastatic Involvement in Axillary Sentinel Nodes: A Rational Basis for a Sensitive Methodology Usable in Daily Practice. Mod Pathol, 15, 641-6.   DOI   ScienceOn
7 Hansen NM, Grube B, Ye X, Turner RR, et al (2009). Impact of micrometastases in sentinel lymph node of patients with invasive breast cancer. J cli oncol, 27, 4679-84.   DOI   ScienceOn
8 Giuliano AE, Dale PS, Turner RR, et al (1995). Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg, 222, 394-401.   DOI   ScienceOn
9 Giuliano AE, Hunt KK, Ballman KV, et al (2011). Blumencranz, A. Marilyn leitch. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis a randomized clinical trial. JAMA, 305, 569-75.   DOI   ScienceOn
10 Ivens D, Hoe AL, Podd TJ (1992). Assessment of morbidity from complete axillary dissection. Br J Cancer, 66, 136-8.   DOI   ScienceOn
11 Krag DN, Anderson SJ, Julian TB, et al (2010). Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol, 11, 927-33.   DOI   ScienceOn
12 Langer G, Marti WR, Guller U, et al (2005). Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases. Ann Surg, 241, 152-8.
13 Lucci A, McCall LM, Beitsch PD, et al (2007). American College of Surgeons Oncology Group. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol, 25, 3657-63.   DOI   ScienceOn
14 Ozcinar B, Muslumanoglu M, Igci A, et al (2011). Clinical significance of micrometastasis in sentinel lymph nodes. Breast, 20, 31-3.   DOI   ScienceOn
15 Pernas S, Gil M, Benitez A, et al (2010). Avoiding axillary treatment in sentinel lymph node micrometastasis of breast cancer: a prospective analysis of axillary or distant recurrence. Ann surg Oncol, 17, 772-7.   DOI
16 Loya A, Guray M, Hennessy BT, et al (2009). Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer, 115, 1605-12.   DOI   ScienceOn
17 Lyman GH, Giuliano AE, Somerfield MR, et al (2005). American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer 10. J Clin Oncol, 23, 7703-20.   DOI   ScienceOn
18 Ryde'n L, Chebil G, Sjostrom L, et al (2007). Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: Analysis of 174 patients after SLN biopsy. EJSO, 33, 33-8   DOI   ScienceOn
19 Seung-Hye Choi SH, Barsky SH, Chang HR (2003). Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. Breast J, 9, 153-62.   DOI   ScienceOn
20 Stitzenberg KB, Calvo BF, Iacocca MV, et al (2002). Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol, 117, 729-37.
21 Yeoh EK, Denham JW, Davies SA (1986). Primary breast cancer: complications of axillary management. Acta Radiol Oncol, 25, 105-8.   DOI
22 Van Zee KJ, Manasseh D-ME, Bevilacqua JLB, et al (2003). A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy. Ann Surg Oncol, 10, 1140-51.   DOI   ScienceOn
23 Veronesi U, Paganelli G, Galimberti V et al (1997). Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet, 349, 1864-7.   DOI   ScienceOn
24 Weaver DL, Krag DN, Ashikaga T, et al (2000). Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma, a multicenter study. Cancer, 88, 1099-107.   DOI
25 Rubio IT, Korourian S, Cowan C, et al (1998). Sentinel lymph node biopsy for staging breast cancer. Am J Surg, 176, 532-7.   DOI   ScienceOn
26 Dowlatshahi K, Fan M, Snider HC, et al (1997). Lymph node micrometastases from breast carcinoma. Cancer, 80, 1188-97.   DOI
27 Giuliano AE (1996). Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol, 62, 75-6.   DOI